NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/30/2026
Back to search
Official data from USPTO
AKTIS ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AKTIS ONCOLOGY
ST13
US500000090561087Class
42
Filing
90561087
Registration
8325579
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
60
Latest update
06/30/2026
Trademark type
Word
Nice classes
42
Filing date
03/04/2021
Registration date
06/30/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-05-00
First use in commerce
2024-05-00
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
LE, KHANH M
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HotKnot Therapeutics, Inc.
Representatives
Vincent J. Badolato BROWN RUDNICK LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical research and scientific research information in the field of radio pharmacological oncology via the Internet; Providing medical and scientific research information in the field of radio pharmacology clinical trials; Providing medical and scientific research information in the field of radiopharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of radiopharmaceuticals and genetics; Scientific investigations for medical purposes in the field of radiopharmacology; Scientific research and development in the field of radiopharmacology
Publications
History of USPTO decisions and trademark events.
60 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/08/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/08/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/29/2026
IUAF
USE AMENDMENT FILED
05/26/2026
EISU
TEAS STATEMENT OF USE RECEIVED
05/26/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/20/2026
EX5G
SOU EXTENSION 5 GRANTED
01/19/2026
EEXT
SOU TEAS EXTENSION RECEIVED
11/14/2025
EXT5
SOU EXTENSION 5 FILED
11/13/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/02/2025
EX4G
SOU EXTENSION 4 GRANTED
05/02/2025
EXT4
SOU EXTENSION 4 FILED
05/02/2025
EEXT
SOU TEAS EXTENSION RECEIVED
05/01/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/25/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/25/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/25/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/25/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/11/2024
EX3G
SOU EXTENSION 3 GRANTED
10/11/2024
EXT3
SOU EXTENSION 3 FILED
10/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/07/2024
EX2G
SOU EXTENSION 2 GRANTED
05/06/2024
EXT2
SOU EXTENSION 2 FILED
05/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/06/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/22/2024
EX1G
SOU EXTENSION 1 GRANTED
02/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/21/2024
NREV
NOTICE OF REVIVAL - E-MAILED
01/05/2024
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
01/05/2024
PETG
PETITION TO REVIVE-GRANTED
01/05/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
01/05/2024
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
12/26/2023
ABN6
ABANDONMENT - NO USE STATEMENT FILED
12/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/30/2023
EXT1
SOU EXTENSION 1 FILED
11/23/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/23/2023
TMBN
TTAB RELEASE CASE TO TRADEMARKS
04/11/2023
OP.T
OPPOSITION TERMINATED NO. 999999
04/11/2023
OP.D
OPPOSITION DISMISSED NO. 999999
04/11/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
02/28/2022
DOCK
ASSIGNED TO EXAMINER
01/03/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2021
PUBO
PUBLISHED FOR OPPOSITION
12/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2021
GNRT
NON-FINAL ACTION E-MAILED
09/26/2021
CNRT
NON-FINAL ACTION WRITTEN
09/26/2021
DOCK
ASSIGNED TO EXAMINER
09/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2021
NWAP
NEW APPLICATION ENTERED
03/08/2021
Continuous trademark protection
Get notified about every new filing that threatens AKTIS ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.